Targeting Pancreatic Cancer Glutamine Dependency Confers Vulnerability to GPX4-Dependent Ferroptosis

The authors elucidated that prolonged glutamine (Gln) restriction or treatment with the Gln antagonist, 6-diazo-5-oxo-L-norleucine, led to growth inhibition and ferroptosis program activation in PDAC.